514 related articles for article (PubMed ID: 22834077)
1. Size matters: gold nanoparticles in targeted cancer drug delivery.
Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
4. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
Elbayoumi TA
Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
[No Abstract] [Full Text] [Related]
5. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
Heneweer C; Gendy SE; Peñate-Medina O
Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
Stylianopoulos T
Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
[No Abstract] [Full Text] [Related]
9. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
Kibria G; Hatakeyama H; Harashima H
Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
[TBL] [Abstract][Full Text] [Related]
10. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
Mohamed S; Parayath NN; Taurin S; Greish K
Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
[TBL] [Abstract][Full Text] [Related]
11. Advances in image-guided intratumoral drug delivery techniques.
Solorio L; Patel RB; Wu H; Krupka T; Exner AA
Ther Deliv; 2010 Aug; 1(2):307-22. PubMed ID: 22816134
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
Wang Y; Wei X; Zhang C; Zhang F; Liang W
Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic model for quantifying the effect of vascular permeability on the choice of drug carrier: a framework for personalized nanomedicine.
Kirtane AR; Siegel RA; Panyam J
J Pharm Sci; 2015 Mar; 104(3):1174-86. PubMed ID: 25583443
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
Jeong EH; Jung G; Hong CA; Lee H
Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
[TBL] [Abstract][Full Text] [Related]
16. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
[TBL] [Abstract][Full Text] [Related]
17. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
Babu A; Templeton AK; Munshi A; Ramesh R
AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
[TBL] [Abstract][Full Text] [Related]
18. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
Ganta S; Talekar M; Singh A; Coleman TP; Amiji MM
AAPS PharmSciTech; 2014 Jun; 15(3):694-708. PubMed ID: 24510526
[TBL] [Abstract][Full Text] [Related]
19. First World Conference on Nanomedicine and Drug Delivery.
Elias E; Thomas S; George A; Sebastian M
Ther Deliv; 2010 Aug; 1(2):225-30. PubMed ID: 22816129
[TBL] [Abstract][Full Text] [Related]
20. Telodendrimer-based nanocarriers for the treatment of ovarian cancer.
Xiao K; Suby N; Li Y; Lam KS
Ther Deliv; 2013 Oct; 4(10):1279-92. PubMed ID: 24116912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
